A recurrent gain of chromosome arm 3q in primary squamous carcinoma of the vagina. 2004

Jens K Habermann, and Kristina Hellman, and Sandra Freitag, and Kerstin Heselmeyer-Haddad, and Ann-Cathrin Hellström, and Keerti Shah, and Gert Auer, and Thomas Ried
Genetics Branch, Center for Cancer Research, National Cancer Institute/NIH, Building 50, Room 1408, 50 South Drive, Bethesda, MD 20892-8010, USA.

Primary carcinomas of the vagina are rare tumors, accounting for 2%-3% of all gynecologic malignancies. Only a few karyotypes based on chromosome banding techniques have been reported. We have, therefore, used comparative genomic hybridization to establish a pattern of genomic imbalances in vaginal squamous cell carcinomas. Analysis of 16 formalin-fixed and paraffin-embedded tumors revealed that 70% of vaginal carcinomas carry relative copy number increases that map to chromosome arm 3q. Other recurring gains were observed on chromosome arms 5p and 19p. Chromosomal losses were infrequent. Most tumors were aneuploid, as measured by image cytometry on Feulgen-stained tissue sections. The cytogenetic data were related to the presence of human papillomavirus genomes, expression of laminin-5 as a marker for invasiveness, and expression levels of markers for proliferative activity and mutated TP53. All relevant clinical data were recorded. The results suggest that vaginal carcinomas are defined by a specific distribution of chromosomal aneuploidies and that the pattern of genomic imbalances is strikingly similar to that observed in squamous cell carcinomas of the uterine cervix. Age at diagnosis (P=0.031), tumor size (P=0.025), and increased laminin-5 expression (P=0.006) have a significant influence on the survival time.

UI MeSH Term Description Entries
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002294 Carcinoma, Squamous Cell A carcinoma derived from stratified SQUAMOUS EPITHELIAL CELLS. It may also occur in sites where glandular or columnar epithelium is normally present. (From Stedman, 25th ed) Carcinoma, Epidermoid,Carcinoma, Planocellular,Carcinoma, Squamous,Squamous Cell Carcinoma,Carcinomas, Epidermoid,Carcinomas, Planocellular,Carcinomas, Squamous,Carcinomas, Squamous Cell,Epidermoid Carcinoma,Epidermoid Carcinomas,Planocellular Carcinoma,Planocellular Carcinomas,Squamous Carcinoma,Squamous Carcinomas,Squamous Cell Carcinomas
D002869 Chromosome Aberrations Abnormal number or structure of chromosomes. Chromosome aberrations may result in CHROMOSOME DISORDERS. Autosome Abnormalities,Cytogenetic Aberrations,Abnormalities, Autosome,Abnormalities, Chromosomal,Abnormalities, Chromosome,Chromosomal Aberrations,Chromosome Abnormalities,Cytogenetic Abnormalities,Aberration, Chromosomal,Aberration, Chromosome,Aberration, Cytogenetic,Aberrations, Chromosomal,Aberrations, Chromosome,Aberrations, Cytogenetic,Abnormalities, Cytogenetic,Abnormality, Autosome,Abnormality, Chromosomal,Abnormality, Chromosome,Abnormality, Cytogenetic,Autosome Abnormality,Chromosomal Aberration,Chromosomal Abnormalities,Chromosomal Abnormality,Chromosome Aberration,Chromosome Abnormality,Cytogenetic Aberration,Cytogenetic Abnormality
D002893 Chromosomes, Human, Pair 3 A specific pair of human chromosomes in group A (CHROMOSOMES, HUMAN, 1-3) of the human chromosome classification. Chromosome 3
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000369 Aged, 80 and over Persons 80 years of age and older. Oldest Old
D014625 Vaginal Neoplasms Tumors or cancer of the VAGINA. Cancer of Vagina,Vaginal Cancer,Cancer of the Vagina,Neoplasms, Vaginal,Vagina Cancer,Vagina Neoplasms,Cancer, Vagina,Cancer, Vaginal,Cancers, Vagina,Cancers, Vaginal,Neoplasm, Vagina,Neoplasm, Vaginal,Neoplasms, Vagina,Vagina Cancers,Vagina Neoplasm,Vaginal Cancers,Vaginal Neoplasm

Related Publications

Jens K Habermann, and Kristina Hellman, and Sandra Freitag, and Kerstin Heselmeyer-Haddad, and Ann-Cathrin Hellström, and Keerti Shah, and Gert Auer, and Thomas Ried
May 2019, European journal of cancer (Oxford, England : 1990),
Jens K Habermann, and Kristina Hellman, and Sandra Freitag, and Kerstin Heselmeyer-Haddad, and Ann-Cathrin Hellström, and Keerti Shah, and Gert Auer, and Thomas Ried
June 1992, Genes, chromosomes & cancer,
Jens K Habermann, and Kristina Hellman, and Sandra Freitag, and Kerstin Heselmeyer-Haddad, and Ann-Cathrin Hellström, and Keerti Shah, and Gert Auer, and Thomas Ried
September 1991, Cancer genetics and cytogenetics,
Jens K Habermann, and Kristina Hellman, and Sandra Freitag, and Kerstin Heselmeyer-Haddad, and Ann-Cathrin Hellström, and Keerti Shah, and Gert Auer, and Thomas Ried
February 1979, Obstetrics and gynecology,
Jens K Habermann, and Kristina Hellman, and Sandra Freitag, and Kerstin Heselmeyer-Haddad, and Ann-Cathrin Hellström, and Keerti Shah, and Gert Auer, and Thomas Ried
May 2001, Cancer genetics and cytogenetics,
Jens K Habermann, and Kristina Hellman, and Sandra Freitag, and Kerstin Heselmeyer-Haddad, and Ann-Cathrin Hellström, and Keerti Shah, and Gert Auer, and Thomas Ried
January 1989, Acta obstetricia et gynecologica Scandinavica,
Jens K Habermann, and Kristina Hellman, and Sandra Freitag, and Kerstin Heselmeyer-Haddad, and Ann-Cathrin Hellström, and Keerti Shah, and Gert Auer, and Thomas Ried
August 1997, Genes, chromosomes & cancer,
Jens K Habermann, and Kristina Hellman, and Sandra Freitag, and Kerstin Heselmeyer-Haddad, and Ann-Cathrin Hellström, and Keerti Shah, and Gert Auer, and Thomas Ried
April 2013, Translational lung cancer research,
Jens K Habermann, and Kristina Hellman, and Sandra Freitag, and Kerstin Heselmeyer-Haddad, and Ann-Cathrin Hellström, and Keerti Shah, and Gert Auer, and Thomas Ried
January 2004, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society,
Jens K Habermann, and Kristina Hellman, and Sandra Freitag, and Kerstin Heselmeyer-Haddad, and Ann-Cathrin Hellström, and Keerti Shah, and Gert Auer, and Thomas Ried
October 2014, Diseases of the colon and rectum,
Copied contents to your clipboard!